{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Q32 Bio Inc."},"Symbol":{"label":"Symbol","value":"QTTB"},"Address":{"label":"Address","value":"ONE PATRIOTS PARK, BEDFORD, Massachusetts, 01730, United States"},"Phone":{"label":"Phone","value":"+1 781 301-7277"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Homology Medicines Inc is a US-based genetic medicines company dedicated to transforming the lives of patients suffering from rare genetic diseases with significant unmet medical needs by curing the underlying cause of the disease. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nuclease-free gene editing modality across a range of genetic disorders."},"CompanyUrl":{"label":"Company Url","value":"https://www.homologymedicines.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Jason A. Campagna","title":"Chief Medical Officer"},{"name":"Jodie P. Morrison","title":"Chief Executive Officer & Director"},{"name":"Saul W. Fink","title":"Chief Technical Officer"},{"name":"Shelia Violette","title":"Chief Scientific Officer & President-Research"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}